Back to search
FDAFDA · Food and drugs·Recall number D-1257-2020

Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11

Published May 6, 2020 · Recall initiated: April 18, 2020

Summary

FDA records drug Class I recall D-1257-2020, published May 6, 2020 and initiated April 18, 2020. Recalling firm: B. Braun Medical Inc; Status: Terminated; Reported quantity: 22,488 Duplex containers; Lot: Lot #: H8J812, Exp. Date 31 JUL 2020. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
B. Braun Medical Inc
Distributor
Product was distributed nationwide within the United States.
Lot
Lot #: H8J812, Exp. Date 31 JUL 2020
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11 recalled?

Yes. FDA published recall D-1257-2020 on May 6, 2020. Reported hazard: Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.

What should I do if I have this product?

Voluntary: Firm initiated · Letter